Nuclear genomic deoxyribonucleic acid (DNA) (DNA)

Nuclear genomic deoxyribonucleic acid (DNA) is the primary repository of genetic information in eukaryotic cells, organized into complex chromosomal structures within the nucleus (NIH, 2023). It serves as the essential template for RNA synthesis and subsequent protein production, making its structural and sequence integrity vital for cellular function, homeostasis, and hereditary transmission (Wikipedia, 2024). In the field of oncology, nuclear DNA is a major therapeutic target for various classes of cytotoxic agents, including alkylating agents that form covalent bonds with DNA bases and intercalators that wedge themselves between base pairs (PubChem, 2024). These drug-DNA interactions disrupt critical processes such as replication and transcription, ultimately triggering cell cycle arrest and apoptosis, particularly in rapidly proliferating malignant cells (StatPearls, 2023). However, because these traditional therapies often lack high specificity for cancer cells, they can cause significant damage to healthy tissues and carry a risk of inducing secondary malignancies due to their inherent mutagenic properties (NCI, 2024). Beyond cancer, genomic DNA is the focus of emerging gene-editing technologies and is central to the pathogenesis of genetic disorders and certain autoimmune conditions like systemic lupus erythematosus (PubMed, 2023).

Other names

Genomic DNANuclear DNAnDNAChromosomal DNADeoxyribonucleic acid

Drugs targeting nuclear DNA typically act through covalent binding (alkylation) of guanine bases, intercalation between base pairs to disrupt the double helix, or the induction of single- and double-strand breaks via topoisomerase inhibition or free radical generation, all of which inhibit DNA replication and transcription (StatPearls, 2023; NCI, 2024).